دورية أكاديمية

Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.

التفاصيل البيبلوغرافية
العنوان: Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.
المؤلفون: Kimani M; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya., Sanders EJ; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.; Nuffield Department of Medicine, Oxford University, Oxford, UK., Chirro O; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya., Mukuria N; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya., Mahmoud S; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya., Rinke de Wit TF; Amsterdam Institute for Global Health and Development, Department of Global Health, University of Amsterdam, Amsterdam, The Netherlands., Graham SM; University of Washington, Seattle, WA, USA., Operario D; Brown University, Providence, RI, USA., van der Elst EM; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
المصدر: International health [Int Health] 2022 May 02; Vol. 14 (3), pp. 288-294.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101517095 Publication Model: Print Cited Medium: Internet ISSN: 1876-3405 (Electronic) Linking ISSN: 18763405 NLM ISO Abbreviation: Int Health Subsets: MEDLINE
أسماء مطبوعة: Publication: 2013- : Oxford : Oxford University Press
Original Publication: -2012: Kidlington, Oxford : Elsevier
مواضيع طبية MeSH: Anti-HIV Agents*/therapeutic use , HIV Infections*/drug therapy , HIV Infections*/prevention & control , Pre-Exposure Prophylaxis* , Sexual and Gender Minorities* , Transgender Persons*, Female ; Gender Identity ; Health Personnel ; Homosexuality, Male ; Humans ; Kenya ; Leadership ; Male
مستخلص: Transgender women (TW) and men who have sex with men (MSM) in Kenya are disproportionately affected by human immunodeficiency virus (HIV) and would benefit substantially from pre-exposure prophylaxis (PrEP). We conducted focus group discussions (FGDs) with healthcare providers (HCPs) and TW/MSM leadership and in-depth interviews (IDIs) with PrEP-experienced MSM and TW to learn about perceived and actual barriers to PrEP programming. Eleven HCP and 10 TW/MSM leaders participated in FGDs before PrEP roll-out (January 2018) and 12 months later. Nineteen PrEP end-users (11 MSM and 8 TW) participated in IDIs. Topic guides explored PrEP knowledge, HIV acquisition risk, gender identity, motivation for PrEP uptake and adherence and PrEP-dispensing venue preferences. Braun and Clarke thematic analysis was applied. Four themes emerged: limited preparedness of HCPs to provide PrEP to TW and MSM, varied motivation for PrEP uptake and persistence among end users, lack of recognition of TW by HCPs and suggestions for PrEP programming improvement from all stakeholders. Providers' reluctance to prescribe PrEP to TW and distrust of TW towards providers calls for interventions to improve the capacity of service environments and staff HIV preventive care. Alternative locations for PrEP provision, including community-based sites, may be developed with TW/MSM leaders.
(© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.)
References: Ann Behav Med. 2014 Feb;47(1):5-16. (PMID: 24317955)
Glob Public Health. 2016 Aug-Sep;11(7-8):1060-75. (PMID: 26963756)
J Int AIDS Soc. 2020 Oct;23 Suppl 6:e25599. (PMID: 33000907)
AIDS Care. 2019 Oct;31(10):1185-1192. (PMID: 31039628)
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):444-453. (PMID: 30550487)
Wellcome Open Res. 2019 Sep 19;4:138. (PMID: 32140565)
SAHARA J. 2012;9(3):160-3. (PMID: 23237071)
J Int AIDS Soc. 2019 Jul;22(7):e25338. (PMID: 31298497)
J Int AIDS Soc. 2020 Oct;23 Suppl 6:e25591. (PMID: 33000918)
BMC Health Serv Res. 2014 Oct 20;14:469. (PMID: 25331607)
J Int AIDS Soc. 2019 Jun;22(6):e25323. (PMID: 31194291)
AIDS Behav. 2018 Jul;22(Suppl 1):35-44. (PMID: 29767324)
PLoS One. 2021 Jan 19;16(1):e0244226. (PMID: 33465090)
AIDS Care. 2020 Aug;32(8):1052-1060. (PMID: 32500722)
Sex Health. 2018 Nov;15(6):578-586. (PMID: 30408432)
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):609-611. (PMID: 27851715)
Lancet HIV. 2017 Sep;4(9):e402-e410. (PMID: 28747274)
J Assoc Nurses AIDS Care. 2009 Sep-Oct;20(5):348-61. (PMID: 19732694)
BMC Health Serv Res. 2020 Jul 31;20(1):704. (PMID: 32736626)
EClinicalMedicine. 2020 Sep 09;26:100541. (PMID: 33089128)
PLoS One. 2016 Apr 13;11(4):e0151716. (PMID: 27073896)
J Int AIDS Soc. 2021 Jan;24(1):e25662. (PMID: 33496371)
معلومات مُعتمدة: 107752 United Kingdom WT_ Wellcome Trust; United Kingdom WT_ Wellcome Trust
فهرسة مساهمة: Keywords: Kenya; MSM; pre-exposure prophylaxis; transgender women
المشرفين على المادة: 0 (Anti-HIV Agents)
تواريخ الأحداث: Date Created: 20210729 Date Completed: 20220509 Latest Revision: 20220716
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC9070506
DOI: 10.1093/inthealth/ihab043
PMID: 34325469
قاعدة البيانات: MEDLINE
الوصف
تدمد:1876-3405
DOI:10.1093/inthealth/ihab043